GW Pharma (GWPH) Tops Q3 EPS by 103c

GW Pharma (NASDAQ: GWPH) reported Q3 EPS of ($0.13), $1.03 better than the analyst estimate of ($1.16). Revenue for the quarter came in at $13.55 million versus the consensus estimate of $12.82 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c